The correlation between aldehyde dehydrogenase-1A1 level and tumor shrinkage after preoperative chemoradiation in locally advanced rectal cancer
Abstract
Keywords
Full Text:
PDFReferences
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base. No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. Available from: http://globocan.iarc.f.
Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012; 2012: 137289. doi: 10.5402/2012/137289
Vasiliou V, Nebert DW. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2005; 2(2): 138–143.
Lindahl R. Aldehyde dehydrogenases and their role in carcinogenesis. Crit Rev Biochem Mol Bio 1992; 27(4-5): 283–335. doi: 10.3109/10409239209082565
Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1(5): 555–567. doi: 10.1016/j.stem.2007.08.014
Marcato P, Dean CA, Giacomantonio CA, et al. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 2011; 10(9): 1378–1384. doi: 10.4161/cc.10.9.15486
Prasmickaite L, Engesæter BØ, Skrbo N, et al. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One 2010; 5(5): e10731. doi: 10.1371/journal.pone.0010731
Avoranta ST, Korkeila EA, Ristamaki RH, et al. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer. Hum Pathol 2013; 44(6): 966–974. doi: 10.1016/j.humpath.2012.10.003
Oh PS, Patel VB, Sanders MA, et al. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. Am J Physiol Gastrointest Liver Physiol 2011; 301(2): G347–G355. doi: 10.1152/ajpgi.00403.2010
Vogler T, Kriegl L, Horst D, et al. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors. Exp Mol Pathol 2012; 92(1):111–117. doi: 10.1016/j.yexmp.2011.10.010
Ishii H, Iwatsuki M, Ieta K, et al. Cancer stem cells and chemoradiation resistance. Cancer Sci 2008; 99(10): 1871–1877. doi: 10.1111/j.1349-7006.2008.00914.x
Kahlert C, Gaitzsch E, Steinert G, et al. Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy. Ann Surg Oncol 2012; 19(13): 4193–4201. doi: 10.1245/s10434-012-2518-9
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45(2): 228–247. doi: 10.1016/j.ejca.2008.10.026
Hessman CJ, Bubbers EJ, Billingsley KG, et al. Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer. Am J Surg 2012; 203(5): 649–653. doi: 10.1016/j.amjsurg.2012.01.003
Balicki D. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. Cell Stem Cell 2007; 1(5): 485–487. doi: 10.1016/j.stem.2007.10.015
Xu SL, Zeng DZ, Dong WG, et al. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma. Int J Clin Exp Pathol 2014; 7(6): 2976–2986.
Lim JS, Kim D, Baek SE, et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2012; 22(8): 1693–1700. doi: 10.1007/s00330-012-2416-3
DOI: http://dx.doi.org/10.30564/amor.v1i2.19
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Rhandyka Rafli, Soehartati A Gondhowiardjo, Adang Bachtiar Kantaatmadja, Sahat Matondang, Ening Krisnuhoni

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.